Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar i disorder

Jan Marie Kozicky, Ivan J. Torres, David J. Bond, Raymond W. Lam, Lakshmi N. Yatham

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Although associations between antipsychotic use and neuropsychological impairment in bipolar I disorder have been observed, there is a lack of studies comparing the effects of specific agents used in this population. We compared performance between patients receiving maintenance treatment with mood stabilizer monotherapy (n=15), adjunctive risperidone (n=15) or quetiapine (n=17), and a group of demographically matched healthy controls (n=28) on tests of executive function (working memory, set shifting, and inhibition) and verbal learning. Despite having a similar clinical profile, patients being treated with risperidone showed significantly impaired working memory, set-shifting, and verbal learning (P<0.05) compared with those either on mood stabilizer monotherapy or adjunctive quetiapine. Although randomized controlled trials are required to confirm the cognitive side effects of medications prescribed for maintenance treatment of bipolar I disorder, preliminary results indicate that addition of risperidone to a mood stabilizer has a negative impact on executive function and verbal learning, an effect not shared with quetiapine.

Original languageEnglish (US)
Pages (from-to)91-99
Number of pages9
JournalInternational Clinical Psychopharmacology
Volume27
Issue number2
DOIs
StatePublished - Mar 1 2012

Keywords

  • Antipsychotics
  • Bipolar disorder
  • Cognition
  • Executive function
  • Learning

Fingerprint Dive into the research topics of 'Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar i disorder'. Together they form a unique fingerprint.

Cite this